Venous Disease Thromboembolic and Amyotrophic Lateral Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

227 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-01

Study Completion Date

2020-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Venous thrombo-embolic (VTE) rates could be high in patients with amyotrophic lateral sclerosis (ALS). Indeed, the rate of VTE in this specific population could be 7-fold higher in this population. Predictiv factors of VTE in patients with ALS are mobility reduction and neurological paralysis. However, to our knowledge, medical littérature is poor concerning VTE and ALS association.

Our first aim is to define annual rate of VTE in ALS population.Then we aim to identify predictiv factors of VTE in this specific population. The studied population is Brest universitary hospital cohort of ALS patient included between 2000 and 2019.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

NCT07299994

Stroke Thrombolysis DAPT(Dual Antiplatelet Therapy) +2 more

NOT_YET_RECRUITING

Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients

NCT03303820

Thrombosis

COMPLETED

Study of Venous Thromboembolism Risk Profiles and Prophylaxis in Neurosurgical Inpatients

NCT04257305

Venous Thromboembolism

COMPLETED

Thromboelastometry and Ischemic Stroke (ThromboPredict)

NCT04870684

Cerebrovascular Stroke Thrombolytic Therapy Mechanical Thrombectomy

UNKNOWN

Direct Intra-arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals

NCT03469206

Ischemic Stroke Large Vessel Occlusion Thrombectomy +2 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lateral Amyotrophic Sclerosis Venous Thrombo-embolic Desease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with amyotrophic lateral sclerosis defined by revised El Escorial score criteria followed in competence centre of Brest Universitary Hospital during 2000 to 2019